Jalra-M 50mg / 850mg Tablet (15'S)

Manufacturer: USV Ltd

Salt Composition : Metformin(850mg), Vildagliptin(50mg)

₹277.56

Strip of 15 Tablet

(Inclusive of all taxes)


Jalra-M 50mg/850mg Tablet can be prescribed alone or together with other diabetes medications. All diabetes medicines work best when used along with a healthy diet and regular exercise. The dose you are given will depend on your condition, blood sugar levels, and what other medicines you are taking. Taking it with meals helps to reduce the chances of developing an upset stomach.


Basic Information

Mechanism Of Action

Jalra M Tablet works by the combined action of both the components - metformin and vildagliptin. It decreases the amount of glucose absorbed from the intestine, lowering the amount of sugar created by the liver and facilitating the entry of sugar into the cells....

Pharmacokinets

  • Metformin is rapidly distributed following absorption and does not bind to plasma proteins. No metabolites or conjugates of metformin have been identified. The absence of liver metabolism clearly differentiates the pharmacokinetics of metformin from that of other biguanides, such as phenformin.
  • Vildagliptin was rapidly absorbed, exhibiting a median tmax of 1.5 to 2 hours at all doses. Across the dose range of 25 to 200 mg, mean elimination half-life (t1/2) showed a trend toward increased values with increasing dose (1.6-2.5 hours).

Side Effects

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Jalra-M

Hypoglycemia (low blood glucose level)

Trembling

Headache

Dizziness

Nausea

Weight gain


Contra Indications

Renal dysfunction.

Congestive cardiac failure needing drug treatment.

Hypersensitivity to metformin.

Acute or chronic metabolic acidosis.

Impaired hepatic function.


Pregnancy Related Information

Jalra-M 50mg/850mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.


Product And Alcohol Interaction

It is unsafe to consume alcohol with Jalra-M 50mg/850mg Tablet.


Breast Feeding Related Information

Jalra-M 50mg/850mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.


Indications

Jalra-M 50mg/850mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may also reduce your chances of having a heart attack or stroke.

Interactions

Jalra-M 50mg/850mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may also reduce your chances of having a heart attack or stroke.

Typical Dosage

Do not chew, crush or break it. Jalra-M 50mg/850mg Tablet

Storage Requirements

Store below 30°C


Effects Of Missed Dosage

If you miss a dose of Jalra-M 50mg/850mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.


Effects Of Overdose

Consult a doctor before taking any medicines.


Expert Advice

You have been prescribed this combination medicine as it can control blood sugar better than metformin alone.

Take it in addition to regular exercise and healthy diet to lower levels of blood sugar.

Take it with food to lower your chance of having an upset stomach.

Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines.

Inform your doctor about your diabetes treatment if you are due to have surgery under a general anaesthetic.

Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting, and stomach pain as Jalra-M 50mg/850mg Tablet may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.

Your doctor may check your kidney and liver function before starting treatment and regularly thereafter. Inform your doctor if you develop symptoms such as abdominal pain, fatigue, loss of appetite, darkened urine or yellowing of the eyes or skin (jaundice).

How To Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jalra-M 50mg/850mg Tablet is to be taken with food.


FAQs

Q. Can the use of Jalra-M 50mg/850mg Tablet lead to hypoglycemia?

The use of Jalra-M 50mg/850mg Tablet does not usually cause hypoglycemia (low blood sugar level) alone. But it could occur if there is insufficient supplementation of calories while taking this medicine. Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. The symptoms are more likely to be noticed if you miss or delay your food, drink alcohol, over-exercise, or take any other antidiabetic medicine along with it. So, regular monitoring of blood sugar levels is important. It is recommended to always carry glucose tablets, honey, or fruit juice with you.

Q. Can the use of Jalra-M 50mg/850mg Tablet cause nausea and vomiting?

Yes, the use of Jalra-M 50mg/850mg Tablet can cause nausea and vomiting. In case of vomiting, drink plenty of water or other fluids by taking small frequent sips. Talk to your doctor if vomiting persists and you notice signs of dehydration, like dark-colored and strong-smelling urine and a low frequency of urination. Do not take any other medicine without speaking to a doctor.

Q. Are there any specific contraindications associated with the use of Jalra-M 50mg/850mg Tablet?

The use of Jalra-M 50mg/850mg Tablet should be avoided in patients with known allergies to any of the components or excipients of this medicine. The use of this medicine is also considered to be harmful to patients with severe kidney impairment, liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.

Q. What is the storage condition for the Jalra-M 50mg/850mg Tablet?

Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children, and other people.